5.23
price up icon5.44%   0.27
after-market アフターアワーズ: 5.15 -0.08 -1.53%
loading
前日終値:
$4.96
開ける:
$5.02
24時間の取引高:
457.86K
Relative Volume:
1.64
時価総額:
$208.16M
収益:
$14.79M
当期純損益:
$-102.44M
株価収益率:
-0.8467
EPS:
-6.1766
ネットキャッシュフロー:
$-91.73M
1週間 パフォーマンス:
-1.51%
1か月 パフォーマンス:
-10.14%
6か月 パフォーマンス:
-38.54%
1年 パフォーマンス:
+117.92%
1日の値動き範囲:
Value
$4.94
$5.38
1週間の範囲:
Value
$4.61
$5.515
52週間の値動き範囲:
Value
$2.44
$15.05

Solid Biosciences Inc Stock (SLDB) Company Profile

Name
名前
Solid Biosciences Inc
Name
セクター
Healthcare (1195)
Name
電話
617-337-4680
Name
住所
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Name
職員
88
Name
Twitter
@SolidBioDMD
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
SLDB's Discussions on Twitter

SLDB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
SLDB 5.23 208.16M 14.79M -102.44M -91.73M -6.1766
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-07-15 アップグレード JP Morgan Neutral → Overweight
2024-06-24 アップグレード Leerink Partners Market Perform → Outperform
2024-05-31 再開されました Piper Sandler Overweight
2024-03-28 開始されました William Blair Outperform
2024-03-15 開始されました Citigroup Buy
2024-03-14 アップグレード Piper Sandler Neutral → Overweight
2023-12-08 開始されました H.C. Wainwright Buy
2021-07-12 開始されました Piper Sandler Neutral
2021-05-27 開始されました Jefferies Buy
2021-03-16 アップグレード SVB Leerink Mkt Perform → Outperform
2021-03-09 開始されました Barclays Overweight
2021-01-08 アップグレード Credit Suisse Underperform → Neutral
2020-07-28 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-05-07 ダウングレード Evercore ISI Outperform → In-line
2019-10-11 開始されました Evercore ISI Outperform
2019-08-29 ダウングレード Citigroup Neutral → Sell
2019-08-19 アップグレード SVB Leerink Mkt Perform → Outperform
2019-08-16 アップグレード Chardan Capital Markets Neutral → Buy
2019-05-14 ダウングレード Credit Suisse Neutral → Underperform
2019-05-14 ダウングレード Goldman Neutral → Sell
2019-02-08 アップグレード Citigroup Sell → Neutral
2019-02-08 ダウングレード SVB Leerink Outperform → Mkt Perform
2018-11-06 開始されました Citigroup Sell
2018-09-06 開始されました Credit Suisse Neutral
すべてを表示

Solid Biosciences Inc (SLDB) 最新ニュース

pulisher
07:09 AM

Cantor Fitzgerald Brokers Reduce Earnings Estimates for SLDB - MarketBeat

07:09 AM
pulisher
Nov 18, 2024

Solid Biosciences Reports Increased Losses Amid R&D Focus - TipRanks

Nov 18, 2024
pulisher
Nov 16, 2024

(SLDB) Investment Analysis - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 16, 2024

Litecoin Climbs 10% In Rally - Investing.com

Nov 16, 2024
pulisher
Nov 16, 2024

Is Solid Biosciences (NASDAQ:SLDB) In A Good Position To Invest In Growth? - Simply Wall St

Nov 16, 2024
pulisher
Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in Solid Bioscie - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Vestal Point Capital, LP Increases Stake in Solid Biosciences Inc. - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

FY2024 Earnings Estimate for SLDB Issued By Chardan Capital - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Solid Biosciences to Present at the Jefferies London Healthcare Conference - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Solid Biosciences CEO to Present at Jefferies London Healthcare Conference | SLDB Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Solid Biosciences' SWOT analysis: DMD therapy stock faces pivotal moment - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Solid Biosciences' SWOT analysis: DMD therapy stock faces pivotal moment By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 12, 2024

JPMorgan Chase & Co. Lowers Solid Biosciences (NASDAQ:SLDB) Price Target to $12.00 - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

HC Wainwright Analysts Decrease Earnings Estimates for SLDB - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Research Analysts Issue Forecasts for SLDB FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Solid Biosciences Inc. (NASDAQ:SLDB) Receives $15.67 Consensus Target Price from Brokerages - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Solid Biosciences (NASDAQ:SLDB) Given Buy Rating at HC Wainwright - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Solid Biosciences: SGT-003 Trial Shows Promise, $171M Cash Runway Despite Wider Q3 Loss | SLDB Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Senhwa Biosciences announces first patient dosed in the Phase I/II study of Silmitasertib in children and young adults with relapsed refractory solid tumors. - PR Newswire

Nov 06, 2024
pulisher
Nov 06, 2024

Where are the Opportunities in (SLDB) - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 04, 2024

Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - The Malaysian Reserve

Nov 04, 2024
pulisher
Nov 04, 2024

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 04, 2024
pulisher
Nov 02, 2024

Millennium Management LLC Reduces Stake in Solid Biosciences Inc - GuruFocus.com

Nov 02, 2024
pulisher
Oct 31, 2024

Sow Good to Hold Third Quarter 2024 Conference Call on Thursday, November 14, 2024 at 10:00 a.m. ET - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Solid Biosciences to Participate at the Truist Securities BioPharma Symposium - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Oct 31, 2024
pulisher
Oct 29, 2024

Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech

Oct 29, 2024
pulisher
Oct 28, 2024

WRN inhibitor IDE-275 gains IND clearance for phase I study in MSI-high tumors - BioWorld Online

Oct 28, 2024
pulisher
Oct 28, 2024

IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors - BioSpace

Oct 28, 2024
pulisher
Oct 26, 2024

(SLDB) Proactive Strategies - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 24, 2024

Pillar Biosciences Receives CPT® Code for FDA Approved oncoReveal™ CDx Pan-Cancer Solid tumor IVD Kit - PR Newswire

Oct 24, 2024
pulisher
Oct 22, 2024

Solid Biosciences CMO sells $18,999 in stock - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

Solid Biosciences CMO sells $18,999 in stock By Investing.com - Investing.com Canada

Oct 22, 2024
pulisher
Oct 22, 2024

Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) Insider Sells 2,923 Shares of Stock - MarketBeat

Oct 22, 2024
pulisher
Oct 16, 2024

Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - Quantisnow

Oct 16, 2024
pulisher
Oct 16, 2024

Seraxis gains IND clearance for islet replacement therapy - BioWorld Online

Oct 16, 2024
pulisher
Oct 15, 2024

(SLDB) Trading Signals - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 14, 2024

Solid Biosciences Inc (SLDB) did well last session? - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Keeping an Eye on Solid Biosciences Inc (SLDB) After Insider Trading Activity - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Cubist Systematic Strategies LLC Sells 74,908 Shares of Huron Consulting Group Inc. (NASDAQ:HURN) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Cubist Systematic Strategies LLC Has $368,000 Stock Position in Metropolitan Bank Holding Corp. (NYSE:MCB) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Cubist Systematic Strategies LLC Makes New $378,000 Investment in Cryoport, Inc. (NASDAQ:CYRX) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Great Lakes Dredge & Dock Co. (NASDAQ:GLDD) Shares Sold by Cubist Systematic Strategies LLC - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Cubist Systematic Strategies LLC Makes New $362,000 Investment in Anterix Inc. (NASDAQ:ATEX) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Aegon Ltd. (NYSE:AEG) Stake Raised by Cubist Systematic Strategies LLC - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

SG Americas Securities LLC Lowers Stock Position in Pool Co. (NASDAQ:POOL) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Lindsay Co. (NYSE:LNN) Shares Sold by Cubist Systematic Strategies LLC - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Cubist Systematic Strategies LLC Sells 23,029 Shares of The St. Joe Company (NYSE:JOE) - Defense World

Oct 14, 2024

Solid Biosciences Inc (SLDB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Solid Biosciences Inc (SLDB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Kahn Clare
Director
Jun 07 '24
Buy
7.67
1,100
8,442
1,100
Ganot Ilan
Director
May 02 '24
Sale
10.33
462
4,772
9,507
Ganot Ilan
Director
Jan 29 '24
Sale
7.99
139
1,111
8,416
PERCEPTIVE ADVISORS LLC
Director
Jan 11 '24
Buy
5.53
3,410,713
18,861,243
6,833,539
RA CAPITAL MANAGEMENT, L.P.
Director
Jan 11 '24
Buy
5.53
904,160
5,000,005
4,192,216
Tan Kevin
CFO & Treasurer
Jan 09 '24
Sale
8.20
3,935
32,267
9,308
Ganot Ilan
Director
Jan 03 '24
Sale
5.30
1,142
6,052
8,167
Cumbo Alexander
President and CEO
Dec 04 '23
Sale
2.77
11,757
32,516
17,439
Howton David T
Chief Operating Officer
Dec 04 '23
Sale
2.78
5,367
14,920
7,684
Herzich Paul
Chief Technology Officer
Dec 04 '23
Sale
2.77
2,968
8,232
4,270
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):